Felbamate
Active substance: felbamate
TABLET · FELBAMATE 400 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals of New York LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- FELBAMATE · 400 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8a99-7f5f-bc9c-246e660b60ad,01a1208c-caef-7d37-b746-44d4ef7bec61,01a1208d-788e-7552-a8a4-003d0c44915d,01a1208d-7893-72f3-8d6c-66eee50d1ad2,01a1208e-a959-7cfe-b6b6-7c908ad243cd;count=22 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 53746-734
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 53746-734 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 53746-734 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 53746-734 · Verified 2026-10-09 · open in source